rethinkPeptides Search
Menu
Study breakdown

Semaglutide Reduces Body Fat in Obese Diabetes Patients Regardless of Formulation

CohortModerate evidence
The takeaway

Both oral and subcutaneous semaglutide significantly reduced fat mass and improved metabolic parameters in obese type 2 diabetes patients over 24 weeks.

Both formulations effective

Daily oral and weekly subcutaneous semaglutide both significantly reduced fat mass, not just total weight

What the researchers found

Both oral and subcutaneous semaglutide significantly reduced fat mass and improved metabolic parameters in adults with obesity and type 2 diabetes over 24 weeks.

Why it matters

Knowing that semaglutide reduces fat specifically — not just total weight — is important because fat loss drives the metabolic health benefits, while muscle preservation maintains function and metabolism.

The numbers in context

24-week study in adults with type 2 diabetes and BMI ≥ 30 kg/m². Both daily oral and weekly subcutaneous semaglutide were used. Body composition measured by bioelectrical impedance analysis.

How the study worked

24-week quasi-experimental retrospective study using bioelectrical impedance analysis to measure body composition changes.

Who was studied

Adults with type 2 diabetes and obesity (BMI ≥ 30 kg/m²)

What this study cannot tell us

Retrospective study design without randomization to oral versus subcutaneous groups. Bioelectrical impedance is less precise than DEXA scanning for body composition.

How to read the evidence

Rated moderate: quasi-experimental retrospective study with body composition data, but non-randomized comparison between oral and subcutaneous groups.

When this study was published

Published in 2024. Adds body composition data to the growing evidence base for semaglutide in both formulations.

The bigger picture

Knowing semaglutide reduces fat specifically (not just weight) and that this occurs with both oral and injectable forms helps patients and doctors choose the most appropriate formulation without worrying about differential body composition effects.

Questions still open

  • Does one formulation produce better fat loss than the other?
  • Would longer treatment duration show continued fat loss or a plateau?

Common questions

Does semaglutide reduce fat or muscle?
This study confirmed semaglutide primarily reduces fat mass, not just total weight, using body composition analysis.
Does the oral pill work as well as the injection?
Both forms produced significant fat mass reduction and metabolic improvement over 24 weeks.

Read the original research

Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus.

Frontiers in endocrinology, 15, 1386542

Citation

Rodríguez Jiménez, Beatriz; Rodríguez de Vera Gómez, Pablo; Belmonte Lomas, Samuel; Mesa Díaz, Ángel Manuel; Caballero Mateos, Irene; Galán, Irene; Morales Portillo, Cristóbal; Martínez-Brocca, María Asunción. (2024). Transforming body composition with semaglutide in adults with obesity and type 2 diabetes mellitus.. Frontiers in endocrinology, 15, 1386542. https://doi.org/10.3389/fendo.2024.1386542